Valuable and timely information on drug therapy issues impacting today's health care and pharmacy environment.
Text
Coxanto (oxaprozin) – New drug approval
October 20, 2023 - The FDA approved Solubiomix’s Coxanto (oxaprozin), for relief of the signs and symptoms of osteoarthritis (OA), rheumatoid arthritis (RA), and juvenile rheumatoid arthritis (JRA).
